Insulin Pumps: Trends in Use

Panel Discussion among 11 Diabetologists

July 2007

Deliverable: Transcripts with key findings.

Project Objectives:

To conduct a panel among diabetologists to discuss the use of continuous subcutaneous insulin injection therapy in patients with type 1 and type 2 diabetes. The primary goals are to understand current treatment practices and market dynamics involving insulin pumps, and to determine physician and patient drivers for this type of therapy.  Additionally;

§            Understand the market size and patient population utilizing insulin pumps

§            To conduct a panel among diabetologists to discuss the use of continuous subcutaneous insulin injection therapy in patients with type 1 and type 2 diabetes. The primary goals are to understand current treatment practices and market dynamics involving insulin pumps, and to determine physician and patient drivers for this type of therapy.

o        Who is involved?

o        What influences the decision to use an insulin pump?

§            Identify physician and patient drivers behind the use of insulin pumps

§            Elucidate the strengths and weakness of current marketed products including Insulet’s OmniPod® Insulin Management System

§            Discuss barriers and facilitators to the use of insulin pump therapy

§            Forecast trends in the use of insulin pumps in the next 1, 3, and 5 years

§            Explore the environment of reimbursement for insulin pumps

Companies and Products Mentioned in This Report

Inclusion Criteria and Respondent Demographics

§    US-based

§    Training and board-certified in endocrinology

§    Two to 30 years of experience post-training

§    From academic medical centers, private practice groups, and community hospitals

§    Familiarity with Insulet’s OmniPod®  (100% of panelists)

§    Users of Insulet’s OmniPod®  (75% of panelists)

§    Request disclosure of past and current consulting relationships

Hospitals Represented: